A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants

Dosage form- IV bolus Dosage- In the five cohorts, each participant receives a single IV bolus administration in one of the five doses based on body weight and followed up for 7 days.

Dosage form- IV bolus Dosage- In the three cohorts, each participant receives a single IV bolus administration for 4 sequential days in one of the three doses based on body weight and followed up for 14 days.

Participants will receive matching placebo across Part 1 and 2 of the study.